Amgen Ventures
2 rounds tracked since 7 August 2025.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $294M
Sectors
Countries
Rounds
- AAVantgarde BioDevelops AAV gene therapies for inherited retinal diseases $141MSeries B · 3 Nov
- Strand TherapeuticsProgrammable mRNA cancer therapies, including IL-12 candidate STX-001 $153MSeries B · 7 Aug
No round matches these filters.